Revolutionizing Heart Surgery: The Rise of Minimally Invasive Techniques
Cardiology has witnessed a significant paradigm shift in recent years, with an increasing emphasis on “gentle” approaches to treating heart valve diseases. The Italian Society of Cardiology (Sic) has been at the forefront of this movement, promoting the adoption of minimally invasive techniques, even for low-risk and younger patients. This shift is backed by the new guidelines of the European Society of Cardiology (Esc) and the European Association of Cardiothoracic Surgery (Eacts), which highlight the benefits of these innovative methods.
Advances in Treating Heart Valve Diseases
According to Pasquale Perrone Filardi, past president of Sic, over half of the population develops heart valve anomalies, particularly affecting the aortic and mitral valves, as they age. These conditions can significantly impact quality of life and increase mortality risk by up to 50% within two years of symptom onset. However, with the advent of minimally invasive techniques, it is now possible to treat all heart valve diseases with reduced hospital stays, fewer complications, and improved life expectancy and quality.
One notable example is Transcatheter Aortic Valve Implantation (TAVI), which has become the standard treatment for aortic stenosis, affecting approximately 1 million people in Italy. As explained by Sic president Gianfranco Sinagra, TAVI allows for the implantation of a biological valve without the need for surgery and general anesthesia, using a small incision in the groin and a catheter. This approach has revolutionized the treatment of aortic stenosis, offering a safer and more effective alternative to traditional surgery.
Minimally Invasive Treatments for Mitral Insufficiency
Regarding mitral insufficiency, which occurs in 90% of patients with heart failure, significant advancements have been made in minimally invasive treatments. Small prostheses or metal “tweezers” can be inserted via catheter, offering a more gentle and effective approach. As highlighted by past president Ciro Indolfi, this procedure is now formally recommended as the first choice treatment for secondary ventricular mitral insufficiency. Additionally, transcatheter therapies are being explored for the tricuspid valve, providing therapeutic alternatives for high-risk patients who were previously ineligible for surgery.
The adoption of these techniques requires the formation of multidisciplinary “Heart Teams,” which can provide comprehensive care and expertise. However, despite the benefits of these minimally invasive approaches, there is still a significant gap in their adoption, particularly among older patients. As Perrone Filardi notes, this not only worsens prognosis but also leads to inefficient use of healthcare resources.
For more information on the latest developments in cardiology and the benefits of minimally invasive techniques, visit Here